真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

前梯度蛋白2(AGR2)多克隆抗體(生物素標(biāo)記)

Biotin-Linked Polyclonal Antibody to Anterior Gradient 2 (AGR2)

GOB4; HAG2; XAG2; AG2; PDIA17; HPC8; Anterior Gradient Protein 2; Protein Disulfide Isomerase Family A,Member 17; Secreted cement gland protein XAG-2 homolog

  • 前梯度蛋白2(AGR2)多克隆抗體(生物素標(biāo)記) 產(chǎn)品包裝(模擬)
  • 前梯度蛋白2(AGR2)多克隆抗體(生物素標(biāo)記) 產(chǎn)品包裝(模擬)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證

特異性

該抗體是針對(duì)AGR2的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實(shí)驗(yàn)中能識(shí)別AGR2。

用法

免疫印跡:0.2-2μg/mL;1:250-2500
免疫組織化學(xué):5-20μg/mL;1:25-100
免疫細(xì)胞化學(xué):5-20μg/mL;1:25-100
最佳稀釋倍數(shù)最終由用戶決定。

儲(chǔ)存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗(yàn)決定,具體方法如下:在37°C孵育48小時(shí),沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲(chǔ),損失率低于5%。

贈(zèng)品

相關(guān)產(chǎn)品

編號(hào) 適用物種:Homo sapiens (Human,人) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPC285Hu01 前梯度蛋白2(AGR2)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
PAC285Hu02 前梯度蛋白2(AGR2)多克隆抗體 WB; IHC; ICC; IP.
PAC285Hu01 前梯度蛋白2(AGR2)多克隆抗體 WB; IHC; ICC; IP.
LAC285Hu71 前梯度蛋白2(AGR2)多克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
MAC285Hu21 前梯度蛋白2(AGR2)單克隆抗體 WB; IHC; ICC; IP.
LAC285Hu72 前梯度蛋白2(AGR2)單克隆抗體(生物素標(biāo)記) WB; IHC; ICC.
SEC285Hu 前梯度蛋白2(AGR2)檢測(cè)試劑盒(酶聯(lián)免疫吸附試驗(yàn)法) Enzyme-linked immunosorbent assay for Antigen Detection.
SCC285Hu 前梯度蛋白2(AGR2)檢測(cè)試劑盒(化學(xué)發(fā)光免疫分析法) Chemiluminescent immunoassay for Antigen Detection.
LMC285Hu 前梯度蛋白2(AGR2)等多因子檢測(cè)試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻(xiàn)

雜志 參考文獻(xiàn)
Cancer Biomarkers Serum AGR2 as an early diagnostic and postoperative prognostic biomarker of human lung adenocarcinoma [MetaPress: n7137r6271u54118]
Molecular & Cellular Proteomics Integrated Proteomic Profiling of Cell Line Conditioned Media and Pancreatic Juice for the Identification of Pancreatic Cancer Biomarkers [PubMed: PMC3205865]
Prostate. Anterior gradient 2 (AGR2): blood-based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype [Pubmed: 22911164]
BMC Cancer. Validation of four candidate pancreatic cancer serological biomarkers that improve the performance of CA19.9 [Pubmed: 24007603]
Clinical Cancer Research Validation of Biomarkers That Complement CA19.9 in Detecting Early Pancreatic Cancer [Pubmed:25239611]
PLoS One AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection [PubMed: 25875093]
Clinical Neurology and Neurosurgery Serum AGR2 as a useful biomarker for pituitary adenomas [S0303846717300045]
Oncotarget Identification, characterization and application of a new peptide against anterior gradient homolog 2 (AGR2) [Pubmed:29937991]
Int J Oncol Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy?induced senescence escape [34913074]
International Journal of Cancer Proteome profiling of enzalutamide‐resistant cell lines and serum analysis identified ALCAM as marker of resistance in castration‐resistant prostate cancer [Pubmed:35689436]
留言咨詢
乌苏市| 都匀市| 临泉县| 调兵山市| 永寿县| 巨野县| 诏安县| 广汉市| 分宜县| 遂平县| 常德市| 互助| 怀安县| 石楼县| 桦川县| 靖宇县| 安吉县| 武胜县| 南漳县| 灌云县| 新源县| 溧水县| 阿图什市| 井研县| 柯坪县| 大竹县| 城步| 敦煌市| 柘城县| 阳曲县| 象州县| 井陉县| 凌海市| 和田市| 平陆县| 鄂托克前旗| 三门峡市| 偃师市| 东海县| 泰顺县| 湖南省|